Litigation Area
Zantac Cancer LawsuitIndustry
Pharmaceutical- If you or a loved one has been diagnosed with bladder, kidney, stomach, colon, or pancreatic cancer after taking Zantac for heartburn relief, call us today at 434-951-7200.
Zantac, the most popular brand of ranitidine, is a medication commonly used to help reduce stomach acid. Sold both over-the-counter and as a prescription, Zantac is one of H2 (histamine-2) blockers used to decrease the amount of acid in the stomach. Over-the-counter versions are used to treat common conditions such as heartburn and indigestion. Prescription options of the product are also available to treat and prevent more severe conditions, such as ulcers and gastroesophageal reflux disease and can be taken by mouth or administered via injection into a muscle or vein.
Recently, the U.S. Food and Drug Administration (FDA) alerted the public that some ranitidine medications, including Zantac, contain low levels of a possible human carcinogen known as N-nitrosodimethylamine (NDMA). The FDA is currently assessing the risk posed to patients from the presence of NDMA.

On Oct. 18, 2019, manufacturer Sanofi announced a voluntary recall of its over-the-counter Zantac due to confirmed contamination with N-Nitrosodimethylamine (NDMA), an impurity that may cause cancer in humans.
Side effects of Ranitidine (Zantac) include:
• Nausea;
• Vomiting;
• Abdominal cramps;
• Stomach cancer;
• Bladder cancer;
• Liver, small intestine, esophageal, colorectal, prostate, and pancreatic cancers;
• Multiple myeloma, leukemia, and non-Hodgkin’s’ lymphoma cancers